Biological Material Analysis TRIZ Cases

Stable pHis analogues overcome histidine degradation to enable specific antibody detection of phosphorylation targets.

Sequential labeling with antigen retrieval increases detection sensitivity for multiple biomarkers while managing imaging complexity.

Fully human monoclonal antibodies bind PD-L1 to inhibit signaling pathways while minimizing adverse side effects from immune reactions.

A lateral flow device detects cerebrospinal fluid leaks using transferrin-binding antibodies and lectins.

Imprinted micelles release electrolyte upon analyte binding to generate electrochemical signals for airborne sampling.

Olfactory receptor fragments on a graphene membrane prevent non-specific adsorption of contaminants, enabling precise detection of target substances.

Magnetic particles bind to CD52 markers on spermatozoa, separating them from epithelial cells while preserving DNA integrity.

Fluorescence-activated cell sorting identifies stable high-producing clones using surface markers, reducing time-consuming methotrexate amplification steps.

Labeled polyunsaturated fatty acids bind GPR72 receptors, resolving screening capability gaps for orphan receptor identification.

Segmenting CD25 enrichment with CD154 depletion resolves purity contamination trade-offs.

Biphenylalanine derivatives differentiate urotensin II and related peptide actions to resolve selectivity limitations.

A three-dimensional gold nanosurface electrode immobilizes concanavalin A to capture norovirus particles directly.

Human monoclonal antibodies neutralize influenza A viruses through specific binding to viral hemagglutinin proteins.

A screening process detects von Willebrand factor and GPIb interaction disorders using recombinant proteins.

Synthetic oligosaccharide conjugates with defined alpha-1,3 linkages bind anti-M antibodies to resolve cross-reactivity issues in brucellosis serodiagnosis.

ERBB3 and IGFBP2 proteins enhance diagnostic sensitivity and specificity, reducing false-positive rates in liver cancer detection.

An ELISPOT assay detects Aspergillus-specific T cells using immunoenzymatic reactions.

MPDD labeling resolves sensitivity and stability trade-offs in endotoxin detection.

Functionalized graphene sensors detect prostate biomarkers via electrical resistance shifts, reducing sample preparation complexity.

Detecting circulating PD-L1 markers in blood resolves tissue collection burdens while maintaining accurate cancer presence discrimination.

Automated flow cytometry detects hematopoietic stem cell colonies using CD14, CD235a, and CD15 marker conjugates for precise quantification.

Antibody targets conserved B7-H3 epitopes to reactivate T-cells across species models.

Optimized CDR sequences resolve specificity and sensitivity contradictions in formalin-fixed paraffin-embedded tissue detection.

Human monoclonal antibodies bind glucocorticoid-induced TNF receptor to stimulate antigen-specific T cell responses.

Anti-glypican-1 antibody binding quantifies soluble glypican-1 levels to resolve PSA test false positives and improve diagnostic specificity.

Hierarchical porous graphene structures resolve selectivity issues in dopamine, ascorbic acid, and uric acid detection.

A multi-protein diagnostic panel combines ELISA and mass spectrometry to detect differential serum behavior.

Anti-PD-1 antibodies block PD-L1 interactions to restore T-cell function, resolving the trade-off between viral suppression and immune response.

Merges serum PSA and urinary AAT thresholds to reduce false positives while maintaining diagnostic sensitivity.

A diagnostic assay isolates cells and uses binding agents to detect minichromosome maintenance proteins and androgen receptors.

Parallel multi-modal detection via a microneedle array improves L-Dopa measurement precision while managing device complexity.

Clonal segmentation isolates the effective antibody species from mixed populations, resolving binding specificity issues in prostate cancer diagnostics.

Specific residue substitutions increase mutant GPCR rigidity in detergent solutions, resolving conformational instability that prevents crystal growth.

An antibody protective agent using 1-sec-butyl-3-methylimidazolium hexafluorophosphate ionic liquid maintains high immunological activity at room temperature.

Arresten biomarker improves early-stage ovarian cancer detection sensitivity and specificity, resolving low accuracy of CA125 and HE4 markers.

A blood-based diagnostic system calculates the Aβ42 to Aβ40 concentration ratio to identify amyloid-positive subjects.

Co-culturing autologous peripheral blood mononuclear cells with matched endothelial cells to simulate human cytokine release.

Affinity molecules bind Nidogen 1 to block angiogenesis and reduce lung metastasis in hepatocellular carcinoma.

Targeted amino acid substitution in the light chain CDR sequence eliminates glycation sites while preserving MUC1 binding specificity.

A linear polymer affinity agent binds mycotoxins via hydrogen bonding for direct surface-enhanced Raman scattering analysis.

Segmented flow through lateral obstacle shifts isolates viable stem cells while preventing clogging during high-volume blood processing.

High-throughput platform identifies therapeutic antibodies and targets via phenotypic binding profiles.

Segmented capture reagents resolve detection limits, enabling accurate measurement of low and high concentration proteins without sample dilution.

A triple immunohistochemistry assay using ERG, TFF3, and HMWCK markers detects prostate cancer in tissue samples.

A detection device measures photovoltage values after immune reactions to identify excessive antigen concentrations automatically.

A nanocomposite-modified biosensor detects and quantifies carcinogenic nitroso compounds in biological samples.

Monoclonal antibodies bind canine and feline Oncostatin M receptor Beta to block signaling pathways.